Evidence map›Paper›PMID 28657598›Full record

ArticleInternational journal of molecular sciences2017

Secretion of IFN-γ Associated with Galectin-9 Production by Pleural Fluid Cells from a Patient with Extrapulmonary Tuberculosis.

Jingge Zhao, Beata Shiratori, Haorile Chagan-Yasutan, Makoto Matsumoto, Toshiro Niki, Michinori Tanaka, Yayoi Takahashi, Osumu Usami, Yugo Ashino, Toshio Hattori

Open access · goldAbstract readCase Reports
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Increased Concentrations of Extracellular Histones in Patients with Tuberculous Pleural Effusion.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Jingge ZhaoDivision of Disaster-Related Infectious Diseases, International Research Institute of Disaster Science, Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan. zhaojingge1987@gmail.com.
Beata ShiratoriKKR Tohoku Kosai Hospital, Kokubun-cho 2-3-11, Aoba-ku, Sendai-shi, Miyagi 980-0803, Japan. beatabucekova@gmail.com.
Haorile Chagan-YasutanDivision of Disaster-Related Infectious Diseases, International Research Institute of Disaster Science, Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan. haorile@gmail.com.
Makoto MatsumotoMicrobiological Research Institute, Otsuka Pharmaceutical Co., Ltd., Kagasuno, Kawauchi-cho, Tokushima 771-0192, Japan. Matsumoto.Makoto@otsuka.jp.
Toshiro NikiDepartment of Immunology, Kagawa University, 1-1 Saiwaicho, Takamatsu, Kagawa 760-0016, Japan. niki.t@galpharma.com.
Michinori TanakaMedical Chemistry Research Institute, Otsuka Pharmaceutical Co., Ltd., Kawauchi-cho, Tokushima 771-0192, Japan. Tanaka.Michinori@otsuka.jp.
Yayoi TakahashiDepartment of Pathology, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan. ytakahashi@patholo2.med.tohoku.ac.jp.
Osumu UsamiDepartment of Respiratory Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan. usamin@mac.com.
Yugo AshinoInternal Medicine of Respiratory Diseases, Sendai City hospital, Asutonaga-machi, Taihaku-ku, Sendai 982-8502, Japan. ya82@yahoo.co.jp.
Toshio HattoriDepartment of Health Science and Social Welfare, Kibi International University, 8 Igamachi, Takahashi 716-8508, Japan. hattorit@kiui.ac.jp.
Tohoku University · JPOtsuka (Japan) · JPKagawa University · JPKibi International University · JPKKR Tohoku Kosai Hospital · JPSendai City Hospital · JPTohoku University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we investigated the role of a matricellular protein galectin-9 (Gal-9) in pleural effusion related to tuberculosis (TB). Plasma and pleural fluid of a patient with extrapulmonary TB were analyzed for cytokine content by ELISA and Luminex. Peripheral blood mononuclear cells (PBMCs) and pleural fluid cells (PFCs) were examined for interferon-γ (IFN-γ) secretion by the enzyme-linked immunospot (ELISPOT) assay or IFN-γ ELISA, for apoptosis and necrosis by Cell Death Detection ELISA, and also underwent cell sorting. The results indicate that compared to plasma, pleural fluid had increased levels of IFN-γ (1.6 vs. 55.5 pg/mL), IL-10, IL-12p40, vascular endothelial growth factor (VEGF), and Gal-9 (3.0 vs. 936.0 pg/mL), respectively. PFCs culture supernatant exhibited higher concentration of Gal-9 compared to PBMCs in culture, consistent with enriched Gal-9 staining in the granuloma that is in closer vicinity to PFCs compared to PBMCs. PFCS displayed higher IFN-γ secretion after stimulation with TB antigens ESAT-6/CFP-10. Furthermore, in PFCs, Gal-9 alone could stimulate IFN-γ synthesis in culture or ELISPOT, which was inhibited by a Gal-9 antagonist lactose, and which may promote apoptosis and necrosis. These findings suggest that Gal-9 could modulate immune responses and participate in immunopathology of pleural effusion during TB.

Indexed as

AdultEnzyme-Linked Immunosorbent AssayFemaleFlow CytometryGalectinsHumansImmunohistochemistryInterferon-gammaMaleTuberculosisGalectinsInterferon-gammaLGALS9 protein, humanELISPOTgalectin-9matricellular proteinpleural effusiontuberculosis

Identifiers

PMID28657598
PMCPMC5535875
OpenAlexW2725831245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.